The information on this page was last updated on 18 February 2022.
The number of shares in issue was 72,308,930
|Shareholder||Number||Ordinary Shares %|
|Icahn School of Medicine at Mount Sinai||10,750,926||14.9%|
|Gilder Gagnon Howe & Co LLC||6,452,824||8.9%|
|Amati Global Investors||2,240,954||3.1%|
|Director||Number||Ordinary Shares %|
|Executive||Number||Ordinary Shares %|
|O. James Sterling||1,805,236||2.5%|
*Christopher Mills is partner and Chief Investment Officer of Harwood Capital LLP. Harwood Capital LLP is Investment Manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Christopher’s shareholding is made up of 6,145,001 ordinary shares held by North Atlantic Smaller Companies Investment Trust PLC, 2,780,000 ordinary shares are held by Oryx International Growth Fund Limited and 249,400 ordinary shares are held by Harwood Capital LLP.
** James McCullough shareholding includes shares held through his family trust, The McCullough 2020 Irrevocable Trust (the "Trust").
Shares not in public hands
As at 18 February 2022 the percentage of AIM securities not in public hands was 34.7%. The securities not in public hands include all significant shareholders over 10%, the directors and executive officers who are classed as persons discharging managerial responsibilities. There are no shares held in treasury.
Rights of shareholders
The rights of shareholders are governed by UK law.
Restrictions in transfer of ordinary shares
There are no restrictions on the transfer of the company’s ordinary shares.
UK City Code on Takeover and Mergers
The Company is subject to the provisions of the City Code on Takeover and Mergers.
Other exchanges and trading platforms
All of the Company's shares are traded on AIM, a market of London Stock Exchange plc, and American Depositary Shares representing the Company’s ordinary shares are listed on the Nasdaq Global Market. The Company's shares are not traded on any other exchange or trading platform.
The Company is subject to the UK City Code on Takeovers and Mergers.